US and China in all-out race for coronavirus vaccine by autumn

America's Moderna raises hopes with initial result, but Beijing ahead in trials

NORIYUKI TAKADA, Nikkei staff writer

TOKYO -- The coronavirus competition between the U.S. and China goes beyond developing a vaccine, as both countries aim to accelerate that process to unprecedented speeds in hopes of starting large-scale production by autumn.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.